Insulin Potentiation Low-Dose Therapy (IPTLDTM) is one of the most innovative techniques in cancer therapy that has come along in the last century. IPTLDTM allows small doses of chemotherapy drugs to be used. The advantages of using small doses is that the drugs become targeted directly to the cancer tissues and not the healthy tissues. Because of that any side-effects are very mild and easily tolerated.
This allows for the therapeutic benefit of selectively targeting cancer cells, while protecting the person from common side-effects of the medications themselves. By selectively targeting cancer cells with chemotherapy drugs, IPTLDTM can be a positive alternative to the harmful side effects of conventional chemotherapy.
Individuals with cancer can participate fully in their recovery, incorporating nutrition, energy and mind-body medicine into their lives for the benefit of their physical and emotional well-being.
How Insulin Potentiation Targeted Low-DoseTM Chemotherapy Is Administered
IPTLDTM treatments are usually done in the morning. The patient must have been fasting since midnight the night before. They should bring a good, solid meal with wholesome foods including fats and proteins with them.
An intravenous line for fluids is started, and the initial blood sugar level is taken. Extra insulin is given to cause the blood sugar level to begin to go down. It takes about 25-35 minutes for the blood sugar level to become low enough to begin to experience mild symptoms.
At this time low-doses of the chemotherapy medications are given. This takes about five minutes. When this is finished, extra glucose is given to the IV line and the patient can eat their meal. This is to promptly return their blood sugar levels to normal. | 
